CN101454291A - 作为选择性大麻素cb1受体拮抗剂的含硫的吡唑衍生物 - Google Patents

作为选择性大麻素cb1受体拮抗剂的含硫的吡唑衍生物 Download PDF

Info

Publication number
CN101454291A
CN101454291A CNA2007800195864A CN200780019586A CN101454291A CN 101454291 A CN101454291 A CN 101454291A CN A2007800195864 A CNA2007800195864 A CN A2007800195864A CN 200780019586 A CN200780019586 A CN 200780019586A CN 101454291 A CN101454291 A CN 101454291A
Authority
CN
China
Prior art keywords
compound
formula
general formula
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800195864A
Other languages
English (en)
Chinese (zh)
Inventor
J·H·M·朗格
C·G·克鲁斯
B·J·范福利特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Abbott Healthcare Products BV
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Publication of CN101454291A publication Critical patent/CN101454291A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2007800195864A 2006-05-31 2007-05-29 作为选择性大麻素cb1受体拮抗剂的含硫的吡唑衍生物 Pending CN101454291A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114752 2006-05-31
EP06114752.6 2006-05-31

Publications (1)

Publication Number Publication Date
CN101454291A true CN101454291A (zh) 2009-06-10

Family

ID=37719834

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800195864A Pending CN101454291A (zh) 2006-05-31 2007-05-29 作为选择性大麻素cb1受体拮抗剂的含硫的吡唑衍生物

Country Status (6)

Country Link
CN (1) CN101454291A (pt)
AR (1) AR061193A1 (pt)
BR (1) BRPI0711902A2 (pt)
MX (1) MX2008015272A (pt)
SA (1) SA07280276B1 (pt)
TW (1) TW200811143A (pt)

Also Published As

Publication number Publication date
MX2008015272A (es) 2009-03-09
TW200811143A (en) 2008-03-01
AR061193A1 (es) 2008-08-13
BRPI0711902A2 (pt) 2011-12-13
SA07280276B1 (ar) 2010-06-15

Similar Documents

Publication Publication Date Title
CN101636397B (zh) 脲类化合物、其制备方法及其医药用途
CN102712625B (zh) 含氮杂芳基衍生物
CN1934091B (zh) 治疗神经变性障碍的咪唑化合物
CN101679279B (zh) 作为5-ht6拮抗剂的磺酰吡唑啉甲脒衍生物
CA2257962A1 (en) Compounds having effects on serotonin-related systems
CN102414204A (zh) 异*唑-哒嗪衍生物
CN102753540B (zh) α4β2神经元烟碱型乙酰胆碱受体的配体
CN101090895A (zh) 芳基磺酰胺调节剂
CN100537564C (zh) 代谢型谷氨酸受体-5的二芳基取代三唑调节剂
CN101990537A (zh) 作为阳性别构调节剂的酰胺衍生物和其使用方法
US11008323B2 (en) Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors
CN102056898A (zh) 作为阳性变构调节剂的酰胺衍生物和其使用方法
CN102741250A (zh) 作为pde10a酶抑制剂的杂芳族苯基咪唑衍生物
CN101952258A (zh) 作为胰岛素分泌刺激剂的喹喔啉酮衍生物、获得它们的方法及其在治疗糖尿病中的用途
CN104955826B (zh) 可用于治疗神经学疾病和病症的螺-喹唑酮衍生物
CN104995182A (zh) 被取代的喹喔啉衍生物及其作为mGluR4的正变构调节剂的用途
JP2016505534A (ja) 置換１，６−ナフチリジン
KR20090016504A (ko) 선택적 칸나비노이드 ｃｂ1 수용체 길항제로서의 황 함유 피라졸 유도체
CA2512243A1 (fr) Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
CN101360741A (zh) 取代的5-杂芳基-1-苯基-吡唑大麻素调节剂
CN105358543B (zh) 作为代谢型谷氨酸受体拮抗剂的乙炔基衍生物
JP6416125B2 (ja) ｍＧｌｕＲ３の正のアロステリックモジュレーター
TW200845963A (en) Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
CN100378108C (zh) 对血清素受体具有亲和力、可用作治疗剂的新型四环芳基磺酰吲哚、其制备方法及其药物组合物
HUE031082T2 (en) Benzazepine Compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1129104

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090610

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1129104

Country of ref document: HK